Furthermore, when ANG, MMP2 are overexpressed and DNMT3b expression reduced in bladder tumors, there is a significant reduction in disease specific survival, thus attesting to ANG, DMT3b and MMP2 ability to further risk stratify patients that may require a more aggressive, even personalized, management plan. This evidence concerns the gene ANG and urinary bladder neoplasm.